THE Therapeutic Goods Administration has issued guidance on "communicating about COVID-19 vaccines," under special arrangements which are in place until 31 Dec 2022.
Any party can create their own content to promote the vaccinations, as long as they do not reference any trade name, active ingredient or sponsor name (e.g. Pfizer or AstraZeneca).
Communications may not make any statement comparing different vaccines, make false or misleading claims or suggest COVID-19 vaccines cannot cause harm or have no side effects.
In addition cash or other rewards can be offered to people who have been fully vaccinated under the Government's national COVID-19 vaccination program.
Any incentives offered must be retrospective and made to all eligible fully vaccinated people.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Jul 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Jul 21
